跳至主要内容
临床试验/NCT04511416
NCT04511416进行中(未招募)3 期

Preventing Cognitive Decline with Metformin:: the MetMemory Study

Garvan Institute of Medical Research1 个研究点 分布在 1 个国家目标入组 242 人开始时间: 2022年7月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
进行中(未招募)
入组人数
242
试验地点
1
主要终点
changes in memory Z-score

研究概览

简要总结

A randomised control study of metformin in people with mild cognitive impairment and without diabetes mellitus to determine effects on cognitive decline and neuroimaging over 3 years.

详细描述

A randomised placebo-control study of metformin in people with mild cognitive impairment and without diabetes mellitus to determine effects on cognitive decline, neuroimaging and biomarkers over 3 years.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
60 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • overweight or obese (body mass index >25.0 kg/m2, waist: women>80 cm, men>94cm;
  • Mild cognitive impairment (Mild Neurocognitive Disorder), based on DSM-5 criteria;
  • Fasting blood glucose <7.0 mmol/L and HbA1c <6.5%;
  • Able to undertake neurocognitive testing in English.
  • Not participating in another trial of drugs or lifestyle modification to reduce cognitive decline.

排除标准

  • Life-threatening illnesses to preclude participation in a 3-year study;
  • Contraindications to the use of metformin (severe heart failure or eGFR <40).

研究组 & 干预措施

Intervention

Active Comparator

Metformin

干预措施: Metformin XR, 500-2000mg nocte (Drug)

Placebo

Placebo Comparator

Placebo

干预措施: Metformin XR, 500-2000mg nocte (Drug)

结局指标

主要结局

changes in memory Z-score

时间窗: 3 years

memory domain Z-score, derived from the following neuropsychological tests: i. Rey Auditory Verbal Learning Test (RAVLT); ii. Total Learning and Delayed recall; iii. the Logical Memory Story A- Immediate Recall; and iv. Delayed Recall tests.

changes in executive function Z-score

时间窗: 3 years

executive function domain Z-score, derived from the following neuropsychological tests: i. Alphabet test; ii. D-KEFS Stroop; iii. Trail Making Test Part B; iv. Weschler Adult Intelligence Scale-IV (WAIS-IV) Digit Span Backward test.

次要结局

  • changes in processing speed domain Z-score(3 years)
  • changes in language performance domain Z-score(3 years)
  • changes in attention performance domain Z-score(3 years)
  • changes in Cogstate brief battery performance Z-score(3 years)
  • changes in total brain volume (cubic millimetres)(3 years)
  • changes in hippocampal volume (cubic millimetres)(3 years)
  • changes in parahippocampal volume (cubic millimetres)(3 years)
  • changes in brain white matter hyperintensity number(3 years)
  • changes in cerebral blood flow (mL / 100 g / min)(3 years)
  • changes in cerebral amyloid tracer standardized uptake value ratio (SUVR)(3 years)
  • changes in cognitive performance Z-score using the NIH tool box(3 years)
  • change in BOLD (blood-oxygen-level-dependent) time-series signals measured by functional magnetic resonance imaging(3 years)
  • changes in biomarkers, including fasting glucose (mmol/L) and insulin (mIU/L), insulin resistance (HOMA-IR index)(3 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Preventing Cognitive Decline with Metformin | 临床试验